Healthcare provider profile · identity verified

Greg W Edens, MD

Allopathic & Osteopathic Physicians|Family Medicine · EASLEY, SC · NPI 1952365173

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Greg W Edens, MD received $39.22 in general payments during 2025 across 2 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 61.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Ozempic, Rybelsus.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 170 claims for Jardiance by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 152 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Rybelsus by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Wegovy as an associated drug or biological on 183056 records involving 75256 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Wegovy by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$39.22

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$24.09	61.4%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$15.13	38.6%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$39.22	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$24.09	1	2025
Source payment records 2025-09-25 · Boehringer Ingelheim Pharmaceuticals, Inc. · $24.09 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$15.13	1	2025
Source payment records 2025-07-22 · Novo Nordisk Inc · $15.13 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$15.13	1	2025
Source payment records 2025-07-22 · Novo Nordisk Inc · $15.13 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	170	exact normalized	Medicare Part D
Ozempic ozempic	2025	Ozempic	2024	152	exact normalized	Medicare Part D
Rybelsus rybelsus	2025	Rybelsus	2024	14 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	170	41
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	152	41
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	14	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Wegovy open payments reported associated product	CMS Open Payments — General Payments 183056 supporting records · 75256 recipient NPIs · example record 1188130070	Wegovy · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	653	185
Atorvastatin Calcium	Atorvastatin Calcium	547	175
Gabapentin	Gabapentin	489	133
Amlodipine Besylate	Amlodipine Besylate	482	151
Omeprazole	Omeprazole	480	149
Lorazepam	Lorazepam	454	85
Lisinopril	Lisinopril	452	133
Pantoprazole Sodium	Pantoprazole Sodium	410	126
Losartan Potassium	Losartan Potassium	381	122
Furosemide	Furosemide	351	100
Tramadol Hcl	Tramadol Hcl	345	90
Tamsulosin Hcl	Tamsulosin Hcl	317	85
Rosuvastatin Calcium	Rosuvastatin Calcium	316	98
Montelukast Sodium	Montelukast Sodium	311	95
Trazodone Hcl	Trazodone Hcl	282	85
Escitalopram Oxalate	Escitalopram Oxalate	271	79
Alprazolam	Alprazolam	263	35
Albuterol Sulfate Hfa	Albuterol Sulfate	256	95
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	252	52
Meloxicam	Meloxicam	242	69
Metformin Hcl	Metformin Hcl	240	82
Metoprolol Succinate	Metoprolol Succinate	238	80
Glimepiride	Glimepiride	232	59
Potassium Chloride	Potassium Chloride	217	66
Hydrochlorothiazide	Hydrochlorothiazide	196	55
Pravastatin Sodium	Pravastatin Sodium	196	68
Methylprednisolone	Methylprednisolone	193	155
Sertraline Hcl	Sertraline Hcl	188	53
Famotidine	Famotidine	177	61
Duloxetine Hcl	Duloxetine Hcl	176	52
Metformin Hcl Er	Metformin Hcl	176	61
Mirtazapine	Mirtazapine	175	45
Clonazepam	Clonazepam	173	31
Ropinirole Hcl	Ropinirole Hcl	173	43
Fluticasone Propionate	Fluticasone Propionate	172	80
Jardiance	Empagliflozin	170	41
Simvastatin	Simvastatin	168	46
Allopurinol	Allopurinol	163	51
Ozempic	Semaglutide	152	41
Zolpidem Tartrate	Zolpidem Tartrate	151	32
Tizanidine Hcl	Tizanidine Hcl	147	48
Ondansetron Odt	Ondansetron	145	59
Azithromycin	Azithromycin	141	106
Meclizine Hcl	Meclizine Hcl	136	38
Ezetimibe	Ezetimibe	134	49
Olmesartan Medoxomil	Olmesartan Medoxomil	127	40
Metoprolol Tartrate	Metoprolol Tartrate	126	39
Eliquis	Apixaban	118	32
Clopidogrel	Clopidogrel Bisulfate	116	35
Finasteride	Finasteride	115	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	114	26
Pioglitazone Hcl	Pioglitazone Hcl	108	29
Temazepam	Temazepam	108	14
Donepezil Hcl	Donepezil Hcl	105	36
Pregabalin	Pregabalin	104	26
Nystatin	Nystatin	103	55
Valsartan	Valsartan	103	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	100	31
Dicyclomine Hcl	Dicyclomine Hcl	98	24
Amoxicillin	Amoxicillin	96	76
Spironolactone	Spironolactone	95	25
Estradiol	Estradiol	94	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	93	67
Citalopram Hbr	Citalopram Hydrobromide	93	26
Fluconazole	Fluconazole	92	46
Promethazine Hcl	Promethazine Hcl	92	20
Doxycycline Hyclate	Doxycycline Hyclate	91	71
Bupropion Xl	Bupropion Hcl	90	29
Cefuroxime	Cefuroxime Axetil	90	62
Celecoxib	Celecoxib	90	26
Esomeprazole Magnesium	Esomeprazole Magnesium	90	20
Diclofenac Sodium	Diclofenac Sodium	87	30
Memantine Hcl	Memantine Hcl	86	22
Carvedilol	Carvedilol	85	29
Nabumetone	Nabumetone	81	27
Diazepam	Diazepam	78	15
Venlafaxine Hcl Er	Venlafaxine Hcl	78	22
Amitriptyline Hcl	Amitriptyline Hcl	77	21
Fluoxetine Hcl	Fluoxetine Hcl	73	25
Sucralfate	Sucralfate	73	20
Vitamin D2	Ergocalciferol (Vitamin D2)	71	21
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	68	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	21
Tresiba Flextouch U-200	Insulin Degludec	67	21
Levofloxacin	Levofloxacin	64	41
Prednisone	Prednisone	62	25
Oxybutynin Chloride Er	Oxybutynin Chloride	60	23
Hydroxyzine Pamoate	Hydroxyzine Pamoate	59	14
Synthroid	Levothyroxine Sodium	56	14
Baclofen	Baclofen	55	23
Linzess	Linaclotide	55	13
Mounjaro	Tirzepatide	55	12
Testosterone Cypionate	Testosterone Cypionate	54	13
Torsemide	Torsemide	54	18
Carisoprodol	Carisoprodol	51	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	51	21
Mupirocin	Mupirocin	49	33
Topiramate	Topiramate	49	15
Triamcinolone Acetonide	Triamcinolone Acetonide	49	31
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	48	29
Colchicine	Colchicine	48	20
Nitroglycerin	Nitroglycerin	48	33
Azelastine Hcl	Azelastine Hcl	46	22
Ondansetron Hcl	Ondansetron Hcl	45	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	45	13
Buspirone Hcl	Buspirone Hcl	44	16
Cephalexin	Cephalexin	44	23
Hydrocortisone	Hydrocortisone	44	16
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	43	suppressed
Enalapril Maleate	Enalapril Maleate	43	suppressed
Alendronate Sodium	Alendronate Sodium	42	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	41	25
Oxycodone Hcl	Oxycodone Hcl	41	15
Primidone	Primidone	41	11
Hydroxyzine Hcl	Hydroxyzine Hcl	40	14
Fenofibrate	Fenofibrate Nanocrystallized	39	11
Chlorthalidone	Chlorthalidone	37	14
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Glipizide	Glipizide	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	12
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	34	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	34	suppressed
Lansoprazole	Lansoprazole	34	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Colestipol Hcl	Colestipol Hcl	33	13
Fenofibrate	Fenofibrate	33	suppressed
Ipratropium Bromide	Ipratropium Bromide	33	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	32	12
Eszopiclone	Eszopiclone	31	suppressed
Klor-Con M20	Potassium Chloride	31	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Trimethoprim	Trimethoprim	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	15
Acyclovir	Acyclovir	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Benazepril Hcl	Benazepril Hcl	29	11
Klor-Con M10	Potassium Chloride	29	12
Ibuprofen	Ibuprofen	27	suppressed
Lubiprostone	Lubiprostone	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Rivastigmine	Rivastigmine	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Praluent Pen	Alirocumab	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Enulose	Lactulose	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	12
Trulicity	Dulaglutide	21	suppressed
Atenolol	Atenolol	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	15
Aripiprazole	Aripiprazole	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Glipizide Er	Glipizide	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Zaleplon	Zaleplon	17	suppressed
Zonisamide	Zonisamide	17	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Dulera	Mometasone/Formoterol	16	suppressed
Lactulose	Lactulose	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Gemtesa	Vibegron	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	13	suppressed
Indapamide	Indapamide	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Metronidazole	Metronidazole	13	11
Movantik	Naloxegol Oxalate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Tegretol	Carbamazepine	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Ramipril	Ramipril	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Wegovy	Semaglutide	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Risperidone	Risperidone	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$39.22 · 2 records	Boehringer Ingelheim Pharmaceuticals, Inc.	JARDIANCE, Ozempic, Rybelsus	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error